WHO to Consider Making Experimental Ebola Treatment More Widely Available — Physician’s First Watch
WHO to Consider Making Experimental Ebola Treatment More Widely Available
By the Editors
The World Health Organization is planning to consult with ethics experts next week on the implications of making an experimental Ebola therapy available to more patients, according to Reuters. Two American aid workers received ZMapp, a combination of three monoclonal antibodies, and had different responses.
Anthony Fauci, director of the NIH's National Institute of Allergy and Infectious Diseases, said on CNN that there are only a few doses currently available. Other experts said it would take months to make enough of the drugs, the Washington Post reports.